Literature DB >> 9767651

Halogenated chalcones with high-affinity binding to P-glycoprotein: potential modulators of multidrug resistance.

F Bois1, C Beney, A Boumendjel, A M Mariotte, G Conseil, A Di Pietro.   

Abstract

Previous studies have shown that flavonoids are modulators of the transmembrane P-glycoprotein (P-gp) which mediates cell multidrug resistance. Some structural elements have been identified which seem to contribute to these compounds' activity. In the present study, a series of halogenated chalcones was prepared to further explore the structural requirements for the P-gp modulation. Four halogenated chalcones have been synthesized and evaluated as potential modulators of P-gp-mediated multidrug resistance of cancer cells by in vitro assays using a purified recombinant domain of the transporter containing the modulator binding site. Halogenated chalcones exhibited high-affinity binding, the 2',4', 6'-trihydroxy-4-iodochalcone behaving as the most potent compound with a KD value in the nanomolar range.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767651     DOI: 10.1021/jm9810194

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.

Authors:  Glaucio Valdameri; Charlotte Gauthier; Raphaël Terreux; Rémy Kachadourian; Brian J Day; Sheila M B Winnischofer; Maria E M Rocha; Véronique Frachet; Xavier Ronot; Attilio Di Pietro; Ahcène Boumendjel
Journal:  J Med Chem       Date:  2012-04-02       Impact factor: 7.446

2.  The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.

Authors:  Johnathan Dallman; Ashabha Lansakara; Thi Nguyen; Chamitha Weeramange; Wasundara Hulangamuwa; Ryan J Rafferty
Journal:  Medchemcomm       Date:  2019-06-11       Impact factor: 3.597

3.  Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.

Authors:  Vineet Kumar; Sarvesh Kumar; Mohammad Hassan; Hailong Wu; Rajesh K Thimmulappa; Amit Kumar; Sunil K Sharma; Virinder S Parmar; Shyam Biswal; Sanjay V Malhotra
Journal:  J Med Chem       Date:  2011-05-19       Impact factor: 7.446

Review 4.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

5.  A novel approach to the synthesis of 6-amino-7-hydroxy-flavone.

Authors:  Lijun Tang; Shufen Zhang; Jinzong Yang; Wentao Gao; Jian Cui; Tianyu Zhuang
Journal:  Molecules       Date:  2004-09-30       Impact factor: 4.411

6.  Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.

Authors:  Feng Deng; Leo Ghemtio; Evgeni Grazhdankin; Peter Wipf; Henri Xhaard; Heidi Kidron
Journal:  Mol Pharm       Date:  2020-06-18       Impact factor: 4.939

7.  Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach.

Authors:  Adhip Rahman; Mohammad Mazharol Hoque; Mohammad A K Khan; Mohammed G Sarwar; Mohammad A Halim
Journal:  Springerplus       Date:  2016-02-24

8.  Comparative Study on the MDR Reversal Effects of Selected Chalcones.

Authors:  A B Ivanova; D I Batovska; I T Todorova; B A Stamboliyska; J Serly; J Molnar
Journal:  Int J Med Chem       Date:  2010-12-29

9.  Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist.

Authors:  Priya Muralidharan; Brielle Jones; Graham Allaway; Shyam S Biswal; Heidi M Mansour
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.